{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:38:57Z","timestamp":1790681937876,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003645","name":"National Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003645","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","redjournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ijrobp.2024.04.014","type":"journal-article","created":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T15:41:14Z","timestamp":1713195674000},"page":"823-834","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Toxicity Evaluation of Dose-Escalation in Hypofractionated Regional Nodal Irradiation for Breast Cancer: A Retrospective Study"],"prefix":"10.1016","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0538-8345","authenticated-orcid":false,"given":"Euidam","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Sung","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0066-3248","authenticated-orcid":false,"given":"Yeon-Joo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungnam","family":"Joo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun sang","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoonsun","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Hyun","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2024.04.014_bib0001","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJMoa1415340","article-title":"Regional nodal irradiation in early-stage breast cancer","volume":"373","author":"Whelan","year":"2015","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ijrobp.2024.04.014_bib0002","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1415369","article-title":"Internal mammary and medial supraclavicular irradiation in breast cancer","volume":"373","author":"Poortmans","year":"2015","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ijrobp.2024.04.014_bib0003","unstructured":"National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology, Treatment by Cancer Type, Breast Cancer, version 4, 2023. Accessed October 28, 2023. https:\/\/www.nccn.org\/guidelines\/guidelines-process\/about-nccn-clinical-practice-guidelines"},{"key":"10.1016\/j.ijrobp.2024.04.014_bib0004","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.radonc.2005.01.005","article-title":"Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: Long-term results of a randomised trial","volume":"75","author":"Yarnold","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.04.014_bib0005","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1470-2045(08)70077-9","article-title":"The UK Standardisation of Breast Radiotherapy (START) trial A of radiotherapy hypofractionation for treatment of early breast cancer: A randomised trial","volume":"9","author":"Group","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2024.04.014_bib0006","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/S0140-6736(08)60348-7","article-title":"The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: A randomised trial","volume":"371","author":"Group","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2024.04.014_bib0007","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1470-2045(13)70386-3","article-title":"The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials","volume":"14","author":"Haviland","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2024.04.014_bib0008","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/028418600750013113","article-title":"Morbidity related to axillary irradiation in the treatment of breast cancer","volume":"39","author":"Bentzen","year":"2000","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2024.04.014_bib0009","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.clon.2005.11.004","article-title":"Complications of breast-cancer radiotherapy","volume":"18","author":"Senkus-Konefka","year":"2006","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.04.014_bib0010","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S1470-2045(18)30813-1","article-title":"Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: A randomised, non-inferiority, open-label, phase 3 trial","volume":"20","author":"Wang","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2024.04.014_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1202544","article-title":"A phase II randomized clinical trial to assess toxicity and quality of life of breast cancer patients with hypofractionated versus conventional fractionation radiotherapy with regional nodal irradiation in the context of COVID-19 crisis","volume":"13","author":"Gil","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2024.04.014_bib0012","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-062034","article-title":"Hypofractionated versus conventional intensity-modulated radiation irradiation (HARVEST-adjuvant): Study protocol for a randomised non-inferior multicentre phase III trial","volume":"12","author":"Xie","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijrobp.2024.04.014_bib0013","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.radonc.2017.10.033","article-title":"Late normal tissue effects in the arm and shoulder following lymphatic radiotherapy: Results from the UK START (Standardisation of Breast Radiotherapy) trials","volume":"126","author":"Haviland","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.04.014_bib0014","first-page":"3","article-title":"The diagnosis and treatment of peripheral lymphedema: 2020 consensus document of the International Society of Lymphology","volume":"53","author":"Committee","year":"2020","journal-title":"Lymphology"},{"key":"10.1016\/j.ijrobp.2024.04.014_bib0015","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.6004\/jnccn.2018.0078","article-title":"Survivorship, version 2.2018, NCCN clinical practice guidelines in oncology","volume":"16","author":"Denlinger","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.ijrobp.2024.04.014_bib0016","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.989466","article-title":"Simultaneous integrated boost within the lymphatic drainage system in breast cancer: A single center study on toxicity and oncologic outcome","volume":"13","author":"Klusen","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2024.04.014_bib0017","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10549-016-4089-0","article-title":"Radiation therapy targets and the risk of breast cancer-related lymphedema: A systematic review and network meta-analysis","volume":"162","author":"Shaitelman","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2024.04.014_bib0018","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/SLA.0000000000003491","article-title":"Risk of lymphedema following contemporary treatment for breast cancer: An analysis of 7617 consecutive patients from a multidisciplinary perspective","volume":"274","author":"Byun","year":"2021","journal-title":"Ann Surg"},{"key":"10.1016\/j.ijrobp.2024.04.014_bib0019","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.breast.2023.02.001","article-title":"The influence of axillary surgery and radiotherapeutic strategy on the risk of lymphedema and upper extremity dysfunction in early breast cancer patients","volume":"68","author":"Zheng","year":"2023","journal-title":"Breast"},{"key":"10.1016\/j.ijrobp.2024.04.014_bib0020","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1200\/JCO.20.00459","article-title":"Quantifying the impact of axillary surgery and nodal irradiation on breast cancer-related lymphedema and local tumor control: Long-term results from a prospective screening trial","volume":"38","author":"Naoum","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.04.014_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-008-0246-4","article-title":"Magnitude of late effects of breast cancer treatments on shoulder function: A systematic review","volume":"116","author":"Levangie","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2024.04.014_bib0022","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ijrobp.2013.02.018","article-title":"A model to estimate the risk of breast cancer-related lymphedema: Combinations of treatment-related factors of the number of dissected axillary nodes, adjuvant chemotherapy, and radiation therapy","volume":"86","author":"Kim","year":"2013","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.04.014_bib0023","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijrobp.2018.08.036","article-title":"Timing of lymphedema after treatment for breast cancer: When are patients most at risk?","volume":"103","author":"McDuff","year":"2019","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.04.014_bib0024","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10549-016-3834-8","article-title":"A longitudinal analysis of chronic arm morbidity following breast cancer surgery","volume":"157","author":"Boquiren","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2024.04.014_bib0025","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1002\/cncr.27467","article-title":"Upper-body morbidity after breast cancer: Incidence and evidence for evaluation, prevention, and management within a prospective surveillance model of care","volume":"118","author":"Hayes","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2024.04.014_bib0026","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3322\/caac.21689","article-title":"Radiation therapy-associated toxicity: Etiology, management, and prevention","volume":"71","author":"Wang","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ijrobp.2024.04.014_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12032-017-1061-8","article-title":"Volumetric modulated arc therapy (VMAT) to deliver nodal irradiation in breast cancer patients","volume":"35","author":"Iorio","year":"2018","journal-title":"Med Oncol"},{"key":"10.1016\/j.ijrobp.2024.04.014_bib0028","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.ijrobp.2020.07.027","volume":"108","author":"Bazan","year":"2020","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.04.014_bib0029","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1200\/JCO.2011.40.8369","article-title":"Predictors of locoregional recurrence after neoadjuvant chemotherapy: Results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27","volume":"30","author":"Mamounas","year":"2012","journal-title":"J Clin Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301624005133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301624005133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T00:30:15Z","timestamp":1727224215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301624005133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0360301624005133"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.04.014","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toxicity Evaluation of Dose-Escalation in Hypofractionated Regional Nodal Irradiation for Breast Cancer: A Retrospective Study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}